The Safety and Impact of Expanded Access to Naloxone in HIV and Primary Care Settings

  • Wermeling, Daniel (PI)

Grants and Contracts Details


Dr. Wermeling will provide consultation in naloxone pharmacokinetics and drug delivery, and assessment of biological plausibility of potential adverse events related to naloxone.
Effective start/end date8/1/164/30/17


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.